Medication Safety in Intravenous Therapy: A Compatibility Study and Analysis of Reaction Products of Dihydralazine and Metamizole
Open Access
- 18 May 2020
- journal article
- research article
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 88 (2) , 25
Abstract
The pharmacotherapy of critically ill patients is challenging due to the variety of drugs that have to be applied. As the majority of pharmaceuticals must be administered intravenously because of the critical condition of the patients, the compatibility of co-applied intravenous drugs is crucial for a safe and successful infusion therapy. Antihypertensive therapy was reported by health care professionals to be ineffective in association with concomitant application of dihydralazine and metamizole (dipyrone). As both drugs are administered in German intensive care units, we analyzed their compatibility, examined the mechanisms of underlying dihydralazine degradation, and identified reaction products of dihydralazine and metamizole. Binary combinations were prepared at the high and the low end of the nominal administration concentration. Validated high performance liquid chromatography/ultraviolet absorption (HPLC-UV) analysis was conducted to quantify drug amount and high performance liquid chromatography/mass spectrometry (HPLC-MS) was used to analyze degradation products. The combinations of dihydralazine and metamizole proved to be incompatible as dihydralazine concentration decreased immediately and considerably. Metamizole also slightly decreased over time. Specific degradation products of dihydralazine were identified and a degradation pathway was postulated. Our findings demonstrate that the intravenous co-administration of dihydralazine and metamizole should be strictly avoided due to the incompatibility of these two drugs.Keywords
This publication has 8 references indexed in Scilit:
- Drug incompatibilities in the adult intensive care unit of a university hospitalRevista Brasileira de Terapia Intensiva, 2016
- Incidence of intravenous drug incompatibilities in intensive care unitsBiomedical Papers, 2015
- Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care unitsCritical Care Medicine, 2010
- Drug incompatibility chemistryAmerican Journal of Health-System Pharmacy, 2009
- Vasorelaxant activity of phthalazinones and related compoundsBioorganic & Medicinal Chemistry Letters, 2006
- Medication errors at the administration stage in an intensive care unitIntensive Care Medicine, 1999
- Stability Studies: Five years LaterAmerican Journal of Health-System Pharmacy, 1988
- Avoiding Common Flaws in Stability and Compatibility Studies of Injectable DrugsAmerican Journal of Health-System Pharmacy, 1983